Combinatorial Approaches for the Identification of Brain Drug Delivery Targets

Author(s): Charles C. Stutz, Xiaobin Zhang, Eric V. Shusta

Journal Name: Current Pharmaceutical Design

Volume 20 , Issue 10 , 2014

Become EABM
Become Reviewer


The blood-brain barrier (BBB) represents a large obstacle for the treatment of central nervous system diseases. Targeting endogenous nutrient transporters that transcytose the BBB is one promising approach to selectively and noninvasively deliver a drug payload to the brain. The main limitations of the currently employed transcytosing receptors are their ubiquitous expression in the peripheral vasculature and the inherent low levels of transcytosis mediated by such systems. In this review, approaches designed to increase the repertoire of transcytosing receptors which can be targeted for the purpose of drug delivery are discussed. In particular, combinatorial protein libraries can be screened on BBB cells in vitro or in vivo to isolate targeting peptides or antibodies that can trigger transcytosis. Once these targeting reagents are discovered, the cognate BBB transcytosis system can be identified using techniques such as expression cloning or immunoprecipitation coupled with mass spectrometry. Continued technological advances in BBB genomics and proteomics, membrane protein manipulation, and in vitro BBB technology promise to further advance the capability to identify and optimize peptides and antibodies capable of mediating drug transport across the BBB.

Keywords: Blood-brain barrier, receptor-mediated transport, brain drug delivery.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Page: [1564 - 1576]
Pages: 13
DOI: 10.2174/13816128113199990459
Price: $65

Article Metrics

PDF: 56